Kintor Pharmaceutical Ltd

Kintor Pharmaceutical Ltd

1.45
HKD
+0.12
(+9.02%)
933.80MMarket Cap
Apr 01Next Earn

Total Valuation

HKD

As of June 30, 2026, Kintor Pharmaceutical Ltd carries a market capitalization of 933.80M, placing it among publicly traded companies globally. Its enterprise value stands at 1.05B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap933.80M
Enterprise Value1.05B

Important Dates

Kintor Pharmaceutical Ltd's next confirmed earnings release is scheduled for April 1, 2027.

Earnings Date4/1/2027

Share Statistics

As of June 30, 2026, Kintor Pharmaceutical Ltd has 488.90M shares outstanding.

Shares Outstanding488.90M

Valuation Ratios

These figures are as of June 30, 2026.

PB Ratio7.40
P/TBV Ratio60.01

Financial Position

As of June 30, 2026, Kintor Pharmaceutical Ltd maintains a current ratio of 0.26, meaning it holds 0.3x the short-term assets needed to cover near-term liabilities.

Current Ratio0.26
Quick Ratio0.17
Debt / Equity122.30

Financial Efficiency

These figures cover the twelve months ended June 30, 2026.

Employee Count123.00

Stock Price Statistics

HKD

As of the close on November 17, 2026, Kintor Pharmaceutical Ltd's stock has declined approximately 32.87% over the past 52 weeks. The 50-day moving average sits at 1.64, while the 200-day moving average is 2.25.

52-Week Price Change-32.87%
50-Day Moving Average1.64
200-Day Moving Average2.25

Balance Sheet

HKD

As of June 30, 2026, Kintor Pharmaceutical Ltd holds 36.17M in cash and equivalents against 154.39M in total debt, resulting in a net debt position of 117.43M. Total book value stands at 126.24M, with working capital of -155.60M providing operational flexibility.

Cash & Cash Equivalents36.17M
Total Debt154.39M
Net Debt117.43M
Equity (Book Value)126.24M
Book Value Per Share0.26
Working Capital-155.60M